Volume 23, Number 9—September 2017
Evaluation of 5 Commercially Available Zika Virus Immunoassays
|Sample collection dpo||In-house Zika virus diagnostic results
||DENV PRNT||Commercial Zika virus serologic assays results
|RT-PCR||MAC-ELISA||PRNT||Euroimmun IgM||Euroimmun IgG||Novatec IgM||Abcam IgM||InBios IgM|
*DENV, dengue virus; dpo, days postsymptom onset; Eq, equivalent; MAC-ELISA, IgM-capture ELISA; ND, not done; Neg, negative; Pos, positive; PRNT, plaque reduction neutralization test; PZ, possible Zika virus; RT-PCR, reverse transcription PCR.
Page created: August 17, 2017
Page updated: August 17, 2017
Page reviewed: August 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.